Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0JEKTY
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
BMS-986183
|
|||||
| Synonyms |
BMS-986183; BMS 986183; BMS986183
Click to Show/Hide
|
|||||
| Organization |
Bristol Myers Squibb Co.
|
|||||
| Drug Status |
Phase 1/2 (Terminated)
|
|||||
| Indication |
In total 1 Indication(s)
|
|||||
| Drug-to-Antibody Ratio |
3 to 3.5
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Glypican-3 (GPC3)
|
Antigen Info | ||||
| Payload Name |
Tubulysin
|
Payload Info | ||||
| Therapeutic Target |
Microtubule (MT)
|
Target Info | ||||
| Conjugate Type |
Random Lysines
|
|||||
